/ResMed%20headquarters%20By%20JHVEPhoto.jpeg)
ResMed Inc. (RMD) is a global health technology company focused on sleep and breathing health, developing cloud-connected medical devices, masks, and digital health solutions for conditions such as sleep apnea and chronic respiratory diseases, alongside software for residential and out-of-hospital care. Headquartered in San Diego, California, ResMed serves customers in more than 140 countries and has a market cap of around $33.1 billion.
The company is slated to announce its first-quarter fiscal year 2027 results on Thursday, Oct. 29, after the market closes. Ahead of the event, analysts expect RMD to report an adjusted EPS of $2.70, up 5.9% from $2.55 in the year-ago quarter. It has surpassed Wall Street’s bottom-line estimates in each of the last four quarters.
